Preclinical News and Research

RSS

Marine bioactive compounds against SARS-CoV-2

A new review paper published in the journal Environmental Science and Pollution Research aimed to determine the possibilities of using biologically active compounds derived from various chemical classes of marine organisms against SARS-CoV-2 infection at various stages of the life cycle of the virus.

6 May 2022

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Breast cancer is the leading cause of cancer-associated death for women worldwide. While chemotherapy is the mainstream treatment for breast cancer, more than 50% of women undergoing chemotherapy will experience at least one chemotherapy-related adverse side effect.

3 May 2022

Funding innovative technologies to revolutionize cancer research

In this interview, News-Medical interviews Michael Weingarten about his work as a director of the Small Business Innovation Research Development Center, helping to fund highly-innovative technologies that are revolutionizing cancer research.

3 May 2022

Research shows how Alzheimer's disease affects the functional architecture of the brain

A new study led by investigators at Massachusetts General Hospital (MGH) shows the impact of early amyloid-β and tau protein accumulation on disrupting connections between brain structures that are important for memory.

3 May 2022

University of Arizona, Oklahoma State University join forces to combat opioid crisis and chronic pain

Robert C. Robbins, MD, president of the University of Arizona, and Kayse Shrum, DO, president of Oklahoma State University, today announced the two institutions’ academic medical centers have joined forces to combat the opioid crisis and chronic pain through research, treatment and education.

30 Apr 2022

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

A new study demonstrated how individualized clinical management of Alzheimer's disease risk was viable in a clinical outpatient setting.

29 Apr 2022

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Researchers at Ural Federal University have proposed the use of polyoxometallate nanoclusters as a carrier for chemotherapy drug. It will help to deliver medications precisely to the focus of a pathological process, such as a cancerous tumor, without toxic effects on healthy cells.

28 Apr 2022

Novel plug-and-play multi-organ chip can be customized to the patient

Engineered tissues have become a critical component for modeling diseases and testing the efficacy and safety of drugs in a human context.

27 Apr 2022

Study describes ultra-structure of Nipah virus surface glycoprotein

A team of US-based scientists has recently demonstrated the cryo-electron microscopic structure and antigenicity of the attachment glycoprotein of the Nipah virus.

27 Apr 2022

The preclinical potential of a herb used in traditional Chinese medicine for the treatment of COVID-19

In a study published in Cells, researchers have been investigating the effects of this extract for use against COVID-19.

27 Apr 2022

Einstein researchers receive $4.2 million NIH grant to detect behavioral markers for Alzheimer's

Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.

27 Apr 2022

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

The Johns Hopkins Kimmel Cancer Center and the Departments of Gynecology/Obstetrics, Neurosurgery and Pathology have been awarded more than $7.8 million for novel, multicenter projects designed to intercept and find cures for several deadly cancers, including pancreatic cancer, ovarian cancer, and the brain cancer known as glioblastoma.

26 Apr 2022

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

The National Comprehensive Cancer Network and the NCCN Foundation today announced seven recipients for the 2022 NCCN Foundation Young Investigator Awards (YIA) Program.

25 Apr 2022

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing.

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Abnormalities in astrocytes may play a key role in causing autism spectrum disorder symptoms

Abnormalities in a type of brain cell called astrocytes may play a pivotal role in causing some behavioral symptoms of autism spectrum disorders, according to a preclinical study by Weill Cornell Medicine investigators.

21 Apr 2022

New research takes a close look at the most prevalent neurotransmitter in the brain

One of the most important molecules in the brain doesn't work quite the way scientists thought it did, according to new work by researchers at Columbia University Vagelos College of Physicians and Surgeons and Carnegie Mellon University.

21 Apr 2022

Revolutionary mRNA vaccine technology: History, facts and the future

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with the burden of the world’s most deadly infectious diseases.

20 Apr 2022

Autonomous robot performs laparoscopic soft tissue surgery with minimal assistance from a surgeon

What if your next surgery was planned and performed by a robot? A team at Johns Hopkins University is working to turn this idea into reality.

20 Apr 2022

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

A scientific team supported by the National Institutes of Health has created a tiny, bioengineered 3-D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair of rare, devastating neuromuscular diseases.

19 Apr 2022

Preclinical News and Research

Marine bioactive compounds against SARS-CoV-2

Novel magnetic therapy complements chemotherapy to enhance breast cancer treatment outcomes

Funding innovative technologies to revolutionize cancer research

Research shows how Alzheimer's disease affects the functional architecture of the brain

University of Arizona, Oklahoma State University join forces to combat opioid crisis and chronic pain

Study explores sex-driven differences in individualized clinical management of Alzheimer’s disease risk

UrFU researchers propose the use of polyoxometallate nanoclusters as chemotherapy drug carrier

Novel plug-and-play multi-organ chip can be customized to the patient

Study describes ultra-structure of Nipah virus surface glycoprotein

The preclinical potential of a herb used in traditional Chinese medicine for the treatment of COVID-19

Einstein researchers receive $4.2 million NIH grant to detect behavioral markers for Alzheimer's

Johns Hopkins scientists receive $7.8 million funding from Break Through Cancer

Recipients for the 2022 NCCN Foundation Young Investigator Awards Program announced

New COVID-19 vaccine proven to be safe and effective in late-stage clinical testing

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Abnormalities in astrocytes may play a key role in causing autism spectrum disorder symptoms

New research takes a close look at the most prevalent neurotransmitter in the brain

Revolutionary mRNA vaccine technology: History, facts and the future

Autonomous robot performs laparoscopic soft tissue surgery with minimal assistance from a surgeon

Scientists create a bioengineered 3D model that mimics the biology of two rare neuromuscular diseases

Event guide: 4th LNP Formulation & Process Development Summit eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics